Pharmafile Logo

Pharmaceutical Development Services Ltd

Pharmaceutical Development Services Limited (PDS) is a pharmaceutical and regulatory consultancy serving the pharmaceutical, biopharmaceutical, medical device and cosmetic industries. The role of PDS is to tell you the current standards for your development regulatory submissions, and what you need to do to meet them. We explain why you need to do what needs to be done, and help you to generate data which will successfully meet the requirements.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Biocity Nottingham, Pennyfoot St, Nottingham, NG1 1GF, United Kingdom
+44 (0)115 912 4277

 Latest Content from PMHub 

Research Partnership has published a new patient Living with Atopic Dermatitis (US) report

White Papers and Resources | February 9, 2018 | Inizio

Living with Atopic Dermatitis (AD) is a report based on a new study conducted amongst adult sufferers and parents of child sufferers. The report consists of 45-minute quantitative and 30-minute qualitative...

Research Partnership has published a new patient Living with Psoriasis (EU) report

White Papers and Resources | February 9, 2018 | Inizio

Living with Psoriasis is a report based on a new study conducted in the main 5EU markets and Belgium and the Netherlands (reports can be purchased for either 5EU or 7EU)....

New opportunities in emerging markets

White Papers and Resources | February 9, 2018 | Inizio

Published in Pharma Exec January 2018 by Rachel Howard

Lynch syndrome: a patient perspective

Blue Latitude Health intern Costantino Ciotti gives an insight into life with Lynch Syndrome, a genetic condition associated with colon cancer. Here he explores the patient’s perspective, including treatment options,...

Battle of the Voice Assistants and Voice Search

At-a-glance crib sheet on how the battle of the voice assistants is shaping up between Amazon, Google, Apple, Microsoft and Samsung.

A Magical Makeover for Lucid Group

Lucid launch their new company branding

World Cancer Day and the role of people-centred care

How people-centred is current cancer care? To support #WorldCancerDay, we explore this question, and look at the ways we can individually and collectively reduce the burden of cancer.

Porterhouse speakers to focus on skills, data sharing and transparency at 17th TIPPA Meeting

Strategies to Improve Operations and Compliance in Medical Communications

Large-scale NHS commissioning models require new partnership approach from pharma

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore how pharma should respond to the NHS’s move towards more collaborative, joined up working

Lucid look set to expand their Macclesfield team

This week Business Unit Heads from Lucid Group met with potential candidates at their Macclesfield office to interview for a number of key roles within the organisation. The recruitment drive...